These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22867932)

  • 1. Management of work disability in rheumatic conditions: a review of non-pharmacological interventions.
    Gignac MA; Jetha A; Bowring J; Beaton DE; Badley EM
    Best Pract Res Clin Rheumatol; 2012 Jun; 26(3):369-86. PubMed ID: 22867932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on work disability in rheumatic diseases.
    Allaire SH
    Curr Opin Rheumatol; 2001 Mar; 13(2):93-8. PubMed ID: 11224732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: A Single-Blind Parallel-Arm Randomized Controlled Trial.
    Keysor JJ; LaValley MP; Brown C; Felson DT; AlHeresh RA; Vaughan MW; Yood R; Reed JI; Allaire SJ
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1022-1029. PubMed ID: 28941189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of primary care depression intervention on employment and workplace conflict outcomes: is value added?
    Smith JL; Rost KM; Nutting PA; Libby AM; Elliott CE; Pyne JM
    J Ment Health Policy Econ; 2002 Mar; 5(1):43-9. PubMed ID: 12529569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capturing all of the costs in NICE appraisals: the impact of inflammatory rheumatic diseases on productivity.
    Bojke L; Spackman E; Hinde S; Helliwell P
    Rheumatology (Oxford); 2012 Feb; 51(2):210-5. PubMed ID: 22267153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of illness studies in rheumatic diseases.
    Fautrel B; Guillemin F
    Curr Opin Rheumatol; 2002 Mar; 14(2):121-6. PubMed ID: 11845016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of the rheumatic diseases in the United States.
    Felts W; Yelin E
    J Rheumatol; 1989 Jul; 16(7):867-84. PubMed ID: 2527991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of employment rate and social status in young adults with childhood-onset rheumatic disease in Catalonia.
    Díaz-Mendoza AC; Modesto Caballero C; Navarro-Cendejas J
    Pediatr Rheumatol Online J; 2015 Jul; 13():29. PubMed ID: 26162373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatology and work.
    Jones AC; Kavanaugh AF; Walker DJ
    Rheumatology (Oxford); 2010 Nov; 49(11):2007-9. PubMed ID: 20947529
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond the hand and upper extremity: The role of hand therapists in care of people with rheumatic diseases.
    Poole JL
    J Hand Ther; 2022; 35(3):339-345. PubMed ID: 35985938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation: a randomized controlled trial.
    Allaire SH; Li W; LaValley MP
    Arthritis Rheum; 2003 Nov; 48(11):3212-8. PubMed ID: 14613285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employment across chronic inflammatory rheumatic diseases and comparison with the general population.
    Mau W; Listing J; Huscher D; Zeidler H; Zink A
    J Rheumatol; 2005 Apr; 32(4):721-8. PubMed ID: 15801031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The net effects of the Project NetWork return-to-work case management experiment on participant earnings, benefit receipt, and other outcomes.
    Kornfeld R; Rupp K
    Soc Secur Bull; 2000; 63(1):12-33. PubMed ID: 10951687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic issues with new rheumatologic therapeutics.
    Kavanaugh A
    Curr Opin Rheumatol; 2007 May; 19(3):272-6. PubMed ID: 17414954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of catastrophising in rheumatic diseases.
    Lerman SF; Haythornthwaite JA
    Clin Exp Rheumatol; 2017; 35 Suppl 107(5):32-36. PubMed ID: 28967374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness.
    Pickett K; Loveman E; Kalita N; Frampton GK; Jones J
    Health Technol Assess; 2015 Oct; 19(86):1-176, v-vi. PubMed ID: 26502807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect costs associated with early exit from work attributable to rheumatic diseases.
    Laires PA; Canhão H; Gouveia M
    Eur J Public Health; 2015 Aug; 25(4):677-82. PubMed ID: 25634954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the International Classification of Functioning, Disability and Health (ICF) to address facilitators and barriers to participation at work.
    Martins AC
    Work; 2015; 50(4):585-93. PubMed ID: 25835961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health services research and policy studies.
    Prashker MJ
    Curr Opin Rheumatol; 1996 Mar; 8(2):106-9. PubMed ID: 8732794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Musculoskeletal disability and rheumatology.
    Russell AS
    J Rheumatol; 1995 Mar; 22(3):573. PubMed ID: 7503855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.